MedTrace Logo

A Study to Compare Rosuvastatin/Ezetimibe and Rosuvastatin in Patients With Diabetes Mellitus and Hypercholesterolemia

NCT03217409 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 85

Last updated 2019-09-23

No results posted yet for this study

Summary

A Study to Compare Rosuvastatin/Ezetimibe Combination and Monotherapy in Patients with Diabetes Mellitus and Hypercholesterolemia.

Conditions

  • Diabetes Mellitus and Hypercholesterolemia

Interventions

DRUG

Rosuvastatin+Ezetimibe

Rosuvastatin 5mg+Ezetimibe 10mg

DRUG

Rosuvastatin

Rosuvastatin 5Mg Tablet

Sponsors & Collaborators

  • Linical Korea

    collaborator INDUSTRY

  • Yuhan Corporation

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-08-10
Primary Completion
2019-04-03
Completion
2019-05-23

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03217409 on ClinicalTrials.gov